|
Wellnex Life Ltd on Monday said it expects growth to continue for the rest of the year and into next year as it reported higher revenue in the quarter. The Melbourne-based consumer healthcare company said revenue increased 46% between January and April to A$8.0 million, around £3.9 million, up from A$5.4 million a year ago. It said gross margin for the period was up 55% to A$3.0 million from A$1.9 million. In April, Wellnex said revenue grew 75% to A$2.6 million and a gross margin of A$1.1 million, compared to A$1.5 million revenue and A$650,000 gross margin in April 2024. The company said headwinds it faced at the start of the year from stock outages and delays in delivering new products have now subsided. Looking ahead, Wellnex said it expects growth to continue for the remainder of the 2025 financial year and into the 2026 financial year. The firm said its brands continue to expand their distribution in Australia, and it is preparing to enter the UK and European markets in the 2026 financial year. Joint Chief Executive Officer Zack Bozinovski said: ‘We continue to see growth across the whole business in both brands and IP licensing opportunities and we are confident that this will continue, which we expect to enhance the future performance of the business. ‘With the recent completion of the dual listing on the AIM market and the removal of A$13 million in liabilities, the company is well positioned to take advantage of the opportunities in the growing consumer healthcare market.’ Last Tuesday, Wellnex said Chair George Tambassis has resigned due to increased external work commitments. The company appointed Non-Executive Director Andrew Vidler as chair on an interim basis. Shares in Wellnex Life closed down 0.6% at 17.40 pence in London on Monday afternoon. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
